Avant Brands Inc. (AVNT.TO)
CAD 0.95
(0.0%)
CAD 0.95
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 5.65 Million CAD | -5.63% |
| 2022 | 12.45 Million CAD | 116.21% |
| 2021 | 5.76 Million CAD | 27.85% |
| 2020 | 4.5 Million CAD | -53.16% |
| 2019 | 9.62 Million CAD | -9.39% |
| 2018 | 10.61 Million CAD | 471.04% |
| 2017 | 1.85 Million CAD | 6527.01% |
| 2016 | 28.05 Thousand CAD | 4.75% |
| 2015 | 26.78 Thousand CAD | 9.14% |
| 2014 | 24.53 Thousand CAD | -29.23% |
| 2013 | 34.67 Thousand CAD | 128.13% |
| 2012 | 15.2 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 2.54 Million CAD | -36.57% |
| 2024 Q2 | 1.77 Million CAD | -30.18% |
| 2024 Q3 | 3.51 Million CAD | 97.7% |
| 2023 Q4 | 4.01 Million CAD | 6.66% |
| 2023 Q1 | 3.01 Million CAD | 2.2% |
| 2023 FY | 11.75 Million CAD | -5.63% |
| 2023 Q2 | 3.08 Million CAD | 2.19% |
| 2023 Q3 | 3.76 Million CAD | 22.15% |
| 2022 FY | 12.45 Million CAD | 116.21% |
| 2022 Q3 | 2.43 Million CAD | -54.23% |
| 2022 Q4 | 2.95 Million CAD | 21.18% |
| 2022 Q1 | 1.74 Million CAD | -34.21% |
| 2022 Q2 | 5.32 Million CAD | 204.81% |
| 2021 Q3 | 1.18 Million CAD | 10.65% |
| 2021 FY | 5.76 Million CAD | 27.85% |
| 2021 Q4 | 2.65 Million CAD | 124.16% |
| 2021 Q2 | 1.07 Million CAD | 25.15% |
| 2021 Q1 | 855 Thousand CAD | 2237.5% |
| 2020 FY | 4.5 Million CAD | -53.16% |
| 2020 Q1 | 1.65 Million CAD | -11.38% |
| 2020 Q2 | 1.72 Million CAD | 3.98% |
| 2020 Q3 | 1.16 Million CAD | -32.66% |
| 2020 Q4 | -40 Thousand CAD | -103.45% |
| 2019 Q3 | 2.1 Million CAD | -29.98% |
| 2019 Q1 | 2.9 Million CAD | -17.88% |
| 2019 Q2 | 2.99 Million CAD | 3.32% |
| 2019 Q4 | 1.87 Million CAD | -10.9% |
| 2019 FY | 9.62 Million CAD | -9.39% |
| 2018 Q2 | 1.48 Million CAD | 18128.57% |
| 2018 Q3 | 2.31 Million CAD | 55.34% |
| 2018 FY | 10.61 Million CAD | 471.04% |
| 2018 Q4 | 3.53 Million CAD | 52.75% |
| 2018 Q1 | 8172.00 CAD | 140.19% |
| 2017 Q1 | 3110.00 CAD | -53.46% |
| 2017 Q4 | -20.33 Thousand CAD | -160.31% |
| 2017 Q3 | 33.71 Thousand CAD | 1544.39% |
| 2017 Q2 | 2050.00 CAD | -34.08% |
| 2017 FY | 1.85 Million CAD | 6527.01% |
| 2016 FY | 28.05 Thousand CAD | 4.75% |
| 2016 Q2 | 8748.00 CAD | 74.79% |
| 2016 Q1 | 5005.00 CAD | -65.24% |
| 2016 Q4 | 6682.00 CAD | -12.31% |
| 2016 Q3 | 7620.00 CAD | -12.89% |
| 2015 FY | 26.78 Thousand CAD | 9.14% |
| 2015 Q3 | 4825.00 CAD | 205.38% |
| 2015 Q1 | 5980.00 CAD | -73.49% |
| 2015 Q2 | 1580.00 CAD | -73.58% |
| 2015 Q4 | 14.39 Thousand CAD | 198.38% |
| 2014 Q3 | 1198.00 CAD | 128.19% |
| 2014 Q1 | 260.00 CAD | -97.19% |
| 2014 FY | 24.53 Thousand CAD | -29.23% |
| 2014 Q4 | 22.55 Thousand CAD | 1782.8% |
| 2014 Q2 | 525.00 CAD | 101.92% |
| 2013 Q1 | 2095.00 CAD | 0.0% |
| 2013 FY | 34.67 Thousand CAD | 128.13% |
| 2013 Q2 | - CAD | -100.0% |
| 2013 Q3 | 23.32 Thousand CAD | 0.0% |
| 2013 Q4 | 9256.00 CAD | -60.32% |
| 2012 FY | 15.2 Thousand CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Aurora Cannabis Inc. | 158.53 Million CAD | 96.431% |
| Avicanna Inc. | 14.59 Million CAD | 61.218% |
| Cardiol Therapeutics Inc. | 29.53 Million CAD | 80.841% |
| Crescita Therapeutics Inc. | 12.32 Million CAD | 54.067% |
| Knight Therapeutics Inc. | 155.54 Million CAD | 96.362% |
| MediPharm Labs Corp. | 23.08 Million CAD | 75.484% |
| OrganiGram Holdings Inc. | 277.81 Million CAD | 97.963% |
| Canopy Growth Corporation | 308.61 Million CAD | 98.166% |
| Willow Biosciences Inc. | 7.55 Million CAD | 25.086% |
| Auxly Cannabis Group Inc. | 40.28 Million CAD | 85.952% |